CGC Logo

CGC Stock Forecast: Canopy Growth Corporation Price Predictions for 2026

Home โ€บ Stocks โ€บ Canada | NASDAQ | Healthcare | Drug Manufacturers - Specialty & Generic

$1.02

-0.02 (-1.92%)

CGC Stock Forecast 2026-2027

$1.02
Current Price
$424.35M
Market Cap
6 Ratings
Buy 1
Hold 4
Sell 1
Wall St Analyst Ratings

Distance to CGC Price Targets

+77.2%
To High Target of $1.81
+77.2%
To Median Target of $1.81
+77.2%
To Low Target of $1.81

CGC Price Momentum

-4.7%
1 Week Change
-5.6%
1 Month Change
-7.3%
1 Year Change
-10.5%
Year-to-Date Change
-57.1%
From 52W High of $2.38
+32.5%
From 52W Low of $0.77
๐Ÿ“Š TOP ANALYST CALLS

Did CGC Make This Month's Elite Buy List?

We don't follow just any analyst โ€” only the top 3% with a proven track record make our cut. See if Canopy Growth is one of their latest high-conviction picks.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest CGC Stock Price Targets & Analyst Predictions

Based on our analysis of 9 Wall Street analysts, CGC has a neutral consensus with a median price target of $1.81 (ranging from $1.81 to $1.81). The overall analyst rating is Buy (6.0/10). Currently trading at $1.02, the median forecast implies a 77.2% upside. This outlook is supported by 1 Buy, 4 Hold, and 1 Sell ratings.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

CGC Analyst Ratings

1
Buy
4
Hold
1
Sell

CGC Price Target Range

Low
$1.81
Average
$1.81
High
$1.81
Current: $1.02

Latest CGC Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for CGC.

Date Firm Analyst Rating Change Price Target
Nov 10, 2025 Benchmark Mike Hickey Hold Upgrade $N/A
Mar 27, 2025 Zuanic & Associates Pablo Zuanic Neutral Initiates $N/A
Jul 9, 2024 Piper Sandler Michael Lavery Underweight Maintains $2.00
Sep 15, 2023 B of A Securities Lisa Lewandowski Underperform Maintains $0.66
Jun 12, 2023 CIBC John Zamparo Underperformer Maintains $0.50
May 2, 2023 Piper Sandler Michael Lavery Underweight Maintains $1.00
Feb 17, 2023 Cantor Fitzgerald Pablo Zuanic Neutral Maintains $3.20
Nov 7, 2022 Cantor Fitzgerald Pablo Zuanic Neutral Maintains $3.30
Nov 2, 2022 Bernstein Nadine Sarwat Underperform Initiates $1.50
Oct 26, 2022 Cantor Fitzgerald Pablo Zuanic Neutral Maintains $3.05
Sep 30, 2022 Barclays Gaurav Jain Underweight Maintains $2.00
Aug 8, 2022 Piper Sandler Michael Lavery Underweight Maintains $2.50
Jun 30, 2022 Piper Sandler Michael Lavery Underweight Maintains $3.00
Jun 8, 2022 Barclays Gaurav Jain Underweight Maintains $3.50
May 31, 2022 Piper Sandler Michael Lavery Underweight Maintains $4.00
Mar 22, 2022 Barclays Underweight Downgrade $N/A
Mar 1, 2022 Barclays Gaurav Jain Equal-Weight Maintains $9.00
Feb 18, 2022 Cantor Fitzgerald Pablo Zuanic Neutral Maintains $11.00
Dec 22, 2021 B of A Securities Lisa Lewandowski Underperform Downgrade $10.00
Dec 20, 2021 Piper Sandler Michael Lavery Underweight Downgrade $7.00

Canopy Growth Corporation (CGC) Competitors

The following stocks are similar to Canopy Growth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Canopy Growth Corporation (CGC) Financial Data

Canopy Growth Corporation has a market capitalization of $424.35M with a P/E ratio of -0.2x. The company generates $204.82M in trailing twelve-month revenue with a -117.3% profit margin.

Revenue growth is -0.3% quarter-over-quarter, while maintaining an operating margin of -17.6% and return on equity of -48.5%.

Valuation Metrics

Market Cap $424.35M
Enterprise Value $211.85M
P/E Ratio -0.2x
PEG Ratio 0.0x
Price/Sales 1.6x

Growth & Margins

Revenue Growth (YoY) -0.3%
Gross Margin +28.8%
Operating Margin -17.6%
Net Margin -117.3%
EPS Growth N/A

Financial Health

Cash/Price Ratio +96.4%
Current Ratio 5.3x
Debt/Equity 33.7x
ROE -48.5%
ROA -2.6%
๐Ÿ’ก SKIP THE NOISE

97% of Analyst Ratings Go Nowhere

We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ€” tracked and updated every Monday and Thursday.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Canopy Growth Corporation logo

Canopy Growth Corporation (CGC) Business Model

About Canopy Growth Corporation

What They Do

Produces and distributes cannabis and related products.

Business Model

The company generates revenue through the production, distribution, and sale of a wide range of cannabis products, including dried flower, extracts, edibles, and vaporizers. It operates in both the adult-use and medical cannabis markets, leveraging its strong presence in Canada and expanding into international markets such as Germany and Australia.

Additional Information

Canopy Growth is headquartered in Smith Falls, Ontario, and was founded in 2009. Its subsidiaries, such as Storz & Bickel, enhance its product offerings by focusing on high-quality, medically certified devices. The company's distribution strategy includes online sales, retail partnerships, and collaboration with provincial retailers, positioning it well within the global cannabis industry.

Company Information

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

960

CEO

Mr. Luc Mongeau

Country

Canada

IPO Year

2018

Canopy Growth Corporation (CGC) Latest News & Analysis

Featured Analysis
Powered by Zacks Investment Research

Should Cresco Stock Be in Your Portfolio Post Q4 Earnings?

CRLBF faces US pricing pressure despite a Q4 sales beat and a strategic entry into Germany's cannabis market, raising questions about near-term upside.

Mar 12, 2026 By Sundeep Ganoria Analyst Blog

Latest News

CGC stock latest news image
Quick Summary

Zacks.com users are closely monitoring Canopy Growth (CGC), indicating potential interest in the stock's future performance.

Why It Matters

Increased interest from Zacks.com users may indicate rising market sentiment or speculation about Canopy Growth, potentially impacting stock performance and investment decisions.

Source: Zacks Investment Research
Market Sentiment: Positive
CGC stock latest news image
Quick Summary

The global cannabis industry is evolving with expanding legalization. Investors are targeting companies poised for long-term growth, particularly Canadian producers.

Why It Matters

The evolving global cannabis industry and expanding legalization suggest growth opportunities. Canadian producers' leadership could indicate strong investment potential in this sector.

Source: MarijuanaStocks
Market Sentiment: Positive
CGC stock latest news image
Quick Summary

Canopy Growth, trading at approximately $1 per share, is acquiring another marijuana business through a cash-and-stock deal.

Why It Matters

Canopy Growth's acquisition could strengthen its market position and growth potential, impacting its stock value and investor sentiment in the cannabis sector.

Source: The Motley Fool
Market Sentiment: Negative
CGC stock latest news image
Quick Summary

Canopy Growth has faced ongoing challenges, showing limited growth while incurring substantial losses and cash burn in recent years.

Why It Matters

Canopy Growth's persistent losses and cash burn signal financial instability, raising concerns about its viability and potential impact on stock performance.

Source: The Motley Fool
Market Sentiment: Neutral
CGC stock latest news image
Quick Summary

Canopy Growth's financial results remain weak, and despite regulatory advancements in the U.S., its future outlook is considered unattractive.

Why It Matters

Canopy Growth's poor financial performance and bleak outlook may signal ongoing challenges, potentially affecting stock value and investor confidence in the cannabis sector.

Source: The Motley Fool
Market Sentiment: Neutral
CGC stock latest news image
Quick Summary

Marijuana stocks, once popular, have seen decreased interest. Canopy Growth, a key company in the sector, continues to face challenges in achieving sustainable profitability.

Why It Matters

Struggles of Canopy Growth indicate ongoing challenges in the marijuana sector, suggesting potential volatility and risks for investors in related stocks.

Source: The Motley Fool
Market Sentiment: Negative

Frequently Asked Questions About CGC Stock

What is Canopy Growth Corporation's (CGC) stock forecast for 2026?

Based on our analysis of 9 Wall Street analysts, Canopy Growth Corporation (CGC) has a median price target of $1.81. The highest price target is $1.81 and the lowest is $1.81.

Is CGC stock a good investment in 2026?

According to current analyst ratings, CGC has 1 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $1.02. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for CGC stock?

Wall Street analysts predict CGC stock could reach $1.81 in the next 12 months. This represents a 77.2% increase from the current price of $1.02. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Canopy Growth Corporation's business model?

The company generates revenue through the production, distribution, and sale of a wide range of cannabis products, including dried flower, extracts, edibles, and vaporizers. It operates in both the adult-use and medical cannabis markets, leveraging its strong presence in Canada and expanding into international markets such as Germany and Australia.

What is the highest forecasted price for CGC Canopy Growth Corporation?

The highest price target for CGC is $1.81 from at , which represents a 77.2% increase from the current price of $1.02.

What is the lowest forecasted price for CGC Canopy Growth Corporation?

The lowest price target for CGC is $1.81 from at , which represents a 77.2% increase from the current price of $1.02.

What is the overall CGC consensus from analysts for Canopy Growth Corporation?

The overall analyst consensus for CGC is neutral. Out of 9 Wall Street analysts, 1 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $1.81.

How accurate are CGC stock price projections?

Stock price projections, including those for Canopy Growth Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: March 15, 2026 7:31 PM UTC
Serious About Growing Your Portfolio?

We highlight 2 high-upside stocks each month – no fluff.

Missedย NVDA?
Donโ€™t Miss the Next One.

Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ€” for free.